SIG | Women's Issues in Epilepsy: Sex Hormones and Epilepsy Care

Tuesday, December 8, 2026 at 7:00 AM to 8:30 AM · 1 hr. 30 min. (America/Denver)
Special Interest Group

Information

This SIG integrates neurophysiologic mechanisms and clinical practice to address the role of sex hormones in epilepsy care across the lifespan. The session includes focused talks on hormonal modulation of neuroexcitability and catamenial epilepsy, interactions between anti-seizure medications and hormonal contraception, and the use of hormone therapy during menopause in people with epilepsy. A moderated panel discussion is focused on key themes and practical implementation. The goal is to provide clinicians with evidence-informed strategies for counseling and to promote consistent hormone-related epilepsy care. This session addresses an area of clinical uncertainty and variability in epilepsy care.
Learning Objective 1
Describe the effects of sex hormones on neuroexcitability and seizure susceptibility, including mechanisms underlying catamenial epilepsy
Learning Objective 2
Identify clinically important interactions between anti-seizure medications and hormonal contraceptives and apply strategies to reduce unplanned pregnancy and worsening seizure frequency
Learning Objective 3
Discuss the role of hormone therapy during menopause in people with epilepsy and provide evidence-informed counseling
Target Audience
CliniciansFellows/TraineesAdvanced Practice Providers (APPs)AdvocatesCommunity Health WorkersNursesPharmacistsScientists/Researchers
Career Stage
Early Career (typically 0-5 years from completion of training)Mid-Career (typically 6-15 years from completion of trainingSenior (typically >15 years from completion of training)
Demographics
ClinicalYoung ProfessionalsResearchFirst-time Attendee
Session Content Includes
and Inclusion (DEI)DiversityEquity
Education Credits
1.5 CME1.5 CNE1.5 CPE
Session ID
WOMENSIG26
Presentation Id
3452267
Event ID
24056
Session Type
Session